No abstract available
MeSH terms
-
Administration, Oral
-
Adult
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use
-
Enoxaparin / administration & dosage
-
Enoxaparin / therapeutic use
-
Female
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / therapeutic use
-
Heparin / administration & dosage
-
Heparin / therapeutic use
-
Heparin, Low-Molecular-Weight / administration & dosage
-
Heparin, Low-Molecular-Weight / therapeutic use
-
Humans
-
Male
-
Meta-Analysis as Topic
-
Pregnancy
-
Pregnancy Complications, Cardiovascular / drug therapy
-
Randomized Controlled Trials as Topic
-
Risk
-
Thrombectomy
-
Thromboembolism / drug therapy
-
Thromboembolism / mortality
-
Thromboembolism / surgery
-
Thromboembolism / therapy*
-
Thrombolytic Therapy
-
Time Factors
-
Vena Cava Filters
-
Venous Thrombosis / drug therapy
-
Venous Thrombosis / mortality
-
Venous Thrombosis / surgery
-
Venous Thrombosis / therapy*
-
Warfarin / administration & dosage
-
Warfarin / therapeutic use
Substances
-
Anticoagulants
-
Enoxaparin
-
Fibrinolytic Agents
-
Heparin, Low-Molecular-Weight
-
Warfarin
-
Heparin